[HTML][HTML] Validation of a single-step, single-tube reverse transcription loop-mediated isothermal amplification assay for rapid detection of SARS-CoV-2 RNA

…, S McDonald, A Greenhalgh… - Journal of medical …, 2020 - microbiologyresearch.org
Introduction. The SARS-CoV-2 pandemic of 2020 has resulted in unparalleled requirements
for RNA extraction kits and enzymes required for virus detection, leading to global shortages…

[HTML][HTML] Feasibility of a refurbished shipping container as a transportable laboratory for rapid SARS-CoV-2 diagnostics

…, N Isles, A Wlodek, A Greenhalgh… - Access …, 2022 - microbiologyresearch.org
Background. Australia’s response to the coronavirus disease 2019 (COVID-19) pandemic
relies on widespread availability of rapid, accurate testing and reporting of results to facilitate …

Precision phosphoproteomic analysis in Chr22q11. 2 amplified NSCLC cells reveals distinct signaling corruption and response to Aurora kinase B inhibition

…, E Wilkes, H Lewis, A Gimenez-Capitan, C Greenhalgh… - Cancer Research, 2021 - AACR
Background: NSCLC cells carrying EGFR mutations can gain resistance to cognate TKIs
through amplification of Chr22q11.2 (Chr22amp), a chromosome segment containing CRKL. …

Abstract LBA013: Phosphoproteomics reveals active drug targets on pathways of resistance and predicts response to midostaurin plus chemotherapy in FLT3 mutant …

…, AD Dokal, A Arruda, R Smith, C Greenhalgh… - Molecular Cancer …, 2021 - AACR
Background: Midostaurin (mido) is approved for treatment of FLT3 mutant-positive (FLT3 + )
acute myeloid leukemia (AML). However, FLT3 mutation is not the only determinant of mido …

[HTML][HTML] Proteomics and Phospho-Proteomics Reveal Predictive Signatures of Response and Mechanisms of Resistance to Midostaurin Plus Chemotherapy in FLT3 …

…, A Dokal, A Arruda, R Smith, C Greenhalgh… - Blood, 2021 - Elsevier
Background: Midostaurin is approved for FLT3 mutant-positive (FLT3+) acute myeloid
leukemia (AML), however efficacy has also been observed in a subpopulation of FLT3 mutant-…

Predictive phosphoproteomic signatures for midostaurin plus chemotherapy response in FLT3 mutant positive acute myeloid leukaemia.

AD Dokal, A Arruda, R Smith, C Greenhalgh, F Patella… - 2021 - ascopubs.org
7019 Background: Midostaurin is approved for FLT3 mutant-positive (FLT3+) acute myeloid
leukemia (AML), however efficacy has also been observed in a subpopulation of FLT3 …

[BOOK][B] Evaluation of the attend anywhere/near me video consulting service in Scotland, 2019-20

J Wherton, T Greenhalgh - 2020 - gov.scot
Attend Anywhere is a video consultations service used across health and care services in
Scotland. In July 2019 the Scottish Government commissioned the University of Oxford (…

[PDF][PDF] Evaluation of the near me video consulting service in Scotland during COVID-19

J Wherton, T Greenhalgh - Edinburgh: Scottish Government, 2020 - theorkneynews.scot
Near Me is the public-facing name for the video consulting (VC) service used across health
and social care in Scotland. Near Me clinics have been established in both primary and …

Eliciting Context-Mechanism-Outcome configurations: Experiences from a realist evaluation investigating the impact of robotic surgery on teamwork in the operating …

N Alvarado, S Honey, J Greenhalgh, A Pearman… - …, 2017 - journals.sagepub.com
This article recounts our experience of eliciting, cataloguing and prioritizing conjectured
Context-Mechanism-Outcome configurations at the outset of a realist evaluation, to provide new …

Islamic Re-use of Antique Mosaic Tesserae

M Greenhalgh - Journal of Mosaic Research, 2008 - dergipark.org.tr
… Such reconstructions follow from a desire to use monolithic columns as supports because,
lacking special arrangements, they cannot be moved without destroying what they support. In …